Silent IBD Clues Lurk a Decade Early

woman holding her stomach in pain with digestive graphic overlay — Photo: Emily frost / Shutterstock

Scientists found warning signs of Crohn’s disease and ulcerative colitis hiding in people’s blood a full decade before doctors diagnosed them.

Quick Take

Researchers studied 2,000 blood samples from 500 people, some of whom later developed Crohn’s disease or ulcerative colitis.
People who later got sick showed narrower, less varied antibody responses years before any symptoms.
Computer models separated future Crohn’s patients from healthy people with strong accuracy, years ahead of diagnosis.
The findings come from early research and have not yet become an approved screening test for the public.

What The Blood Samples Actually Showed

Researchers at Mount Sinai pulled 2,000 stored blood samples from 500 people. Of those, 200 went on to develop Crohn’s disease, 200 developed ulcerative colitis, and 100 stayed healthy as matched controls. Samples were drawn at diagnosis, and again roughly two, four, and ten years earlier, letting scientists look backward in time at each person’s immune history.

The team scanned each sample against 357,000 viral, bacterial, and other antigens, essentially checking how many different threats each person’s antibodies had learned to recognize. People who later developed inflammatory bowel disease (IBD) showed a noticeably smaller, less diverse set of antibody responses than the healthy group, even a decade out.

That narrower antibody range wasn’t random noise. Future Crohn’s patients carried higher responses to herpesviruses and a bacterial protein called flagellin, while their defenses against encapsulated bacteria, including the bug that causes pneumonia, were weaker. Future ulcerative colitis patients showed different shifts, tied to rhinoviruses and a self-protein called MADD.

How Well The Models Predicted Who Got Sick

Using these antibody patterns, machine-learning models separated future Crohn’s patients from healthy controls with an accuracy score of 0.90 out of a perfect 1.0. For ulcerative colitis, the score was 0.84. Those numbers describe how well the model sorted people in this study, not a guarantee for any single patient walking into a clinic today.

The antibody signatures also appeared to carry extra information about disease severity. Patients whose Crohn’s disease later turned complicated, meaning it caused blockages or other serious problems, showed different antibody patterns than those whose disease stayed milder. The elevated herpesvirus and flagellin signals showed up especially often in that more severe group.

This Discovery Builds On Years Of Earlier Clues

This isn’t the first time researchers have caught IBD announcing itself early through blood tests. Studies going back decades found antibodies called ASCA and pANCA showing up in blood an average of five years before Crohn’s diagnosis. Later work through the PREDICTS research program found similar antimicrobial antibodies roughly six years out. A separate protein-based study found markers reaching 87 percent accuracy just one year before diagnosis.

A Danish study looking at blood work from nearly 20,000 IBD patients and more than 4 million other people found widespread blood changes stretching back as far as eight years before diagnosis. Together, these studies paint a consistent picture: the gut doesn’t suddenly turn on patients the day symptoms start. The immune system has been quietly shifting for years beforehand.

Why This Isn’t A Doctor’s Office Test Yet

None of this means a lab can hand someone a blood result today and tell them they will get Crohn’s disease. The study compared future IBD patients only against healthy controls, not against people with similar symptoms from irritable bowel syndrome, celiac disease, or ordinary stomach infections. Without that comparison, doctors can’t yet tell whether this antibody pattern is unique to IBD or shows up in other gut troubles too.

The full peer-reviewed study, cohort details, and statistical methods also haven’t been made fully public yet, which limits outside experts’ ability to double-check the numbers. That’s a normal, early step in medical research, not a reason to dismiss the finding. It just means the next job is testing this antibody model on a brand-new group of people who haven’t been diagnosed yet, to see if it holds up outside the original study group.

Your immune system may show signs of inflammatory bowel disease years before symptoms appear. In a study of 500 people, distinct antibody patterns linked to Crohn’s disease and ulcerative colitis were detectable up to a decade before diagnosis.

— Sammy No Filter 🦅 (@SammyNoFilter) October 25, 2026

For now, the real takeaway is simpler than a diagnostic breakthrough. The body appears to drop warning signs about gut disease long before anyone feels sick enough to see a doctor. Turning that warning into something a family physician can actually use will take more studies, more patients, and more time.